Google: Analysts' New Targets, Estimates

Click here for Analysts' Upgrades, Downgrades.

Editor's Note: Green and red arrows refer to intraday stock price movement.

NEW YORK ( TheStreet) -- Alimera Sciences ( ALIM) price target cut at Citi to $12 from $15 after FDA did not approve lluvien NDA. Maintain Buy rating.

Google ( GOOG) target increased at Kaufman to $690. Company should benefit from strong domestic online holiday sales.

Rovi ( ROVI) estimates, target raised at Wedbush. Shares of ROVI now seen reaching $59, according to Wedbush Securities. Estimates also increased, to match the company's new guidance, following the SNIC acquisition.

Time Warner Cable ( TWC) target boosted at Argus to $75. Company is leveraged to benefit from a recovery in the economy. Buy rating.

This article was written by a staff member of TheStreet.

More from Stocks

GlaxoSmithKline, Pfizer Form Consumer Healthcare Group with $13 Billion in Sales

GlaxoSmithKline, Pfizer Form Consumer Healthcare Group with $13 Billion in Sales

Former Disney COO Emerges as Leading Candidate For CBS Job

Former Disney COO Emerges as Leading Candidate For CBS Job

Micron Shares Tumble on Mixed Earnings Results

Micron Shares Tumble on Mixed Earnings Results

Amazon and Oracle's Beef Is Carrying Over to the Courtroom in JEDI Dispute

Amazon and Oracle's Beef Is Carrying Over to the Courtroom in JEDI Dispute

U.S. Stocks Bounce Ahead of Fed Rate Hike Comments -- One Key Trend to Remember

U.S. Stocks Bounce Ahead of Fed Rate Hike Comments -- One Key Trend to Remember